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ABSTRACT 
Chronic low-level exposure to environmental toxins, including cadmium (Cd) , is 
a growing problem in the industrialized world. One promising strategy for protec- 
tion from these toxins is the use of low-dose exposure of environmental chemicals 
to induce cell tolerance and recovery, a phenomenon known as "protective hormesis". 
Hormetic [low-dose stimulatory] effects occur in a variety of systems and with a 
number of chemicals. Cd is a potent carcinogen in rodents and has also been linked 
to human lung and prostate cancers. In the present study, we have evaluated the 
protective effects of low and ultra-low dose, long-term Cd exposure in the normal 
human prostate cells, RWPE-1. Cells were exposed to low and ultra-low doses (0, 0 
(S3'j), loe7, 10-lR, or  M) of Cd for 20 weeks followed by 
treatment with 10" MCd for another 8 weeks. Continuous exposure of RWPE-1 cells 
to 10" MCd results in malignant transformation. However, cells pretreated with low 
and ultra-low doses of Cd had delayed transformation compared with controls. In 
addition, the number of transformed cell mounds was lower in pretreated cells 
indicating that low and ultra-low dose exposure had protective effects against high- 
dose Cd induced carcinogenesis. The expression of metallothionein (MT), the 
primary Cd detoxification protein, was induced by low-dose exposure to Cd and 
maintained during the 20 weeks. In addition, MT-1G mRNA was up-regulated 2- to 
3-fold by low-dose and ultralowdose Cd exposures and may be the mechanism of 
protective hormesis in this model. MT-1G mRNA might also serve as a biological 
indicator of very low-dose environmental Cd exposure. 
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INTRODUCTION 
In the n~odern era, humans and other living organisms are frequently exposed 
to environmental pollutants such as heavy metals that have significant adverse 
biological effects. However, exposure to low doses of toxic agents are reported to 
have beneficial protective effects in a number of models (Davis and Svendsgaard, 
1990; Stebbing 2000; Calabrese and Baldwin 2001), a phenomenon known as 
"protective hormesis". Horinesis is the stirnulatory effect of low-dose toxin exposures 
and has been demonstrated in a wide variety of organisms and for a large number 
of cht.micals and radiation (Calabrese and Baldwin 2003). Cadmium (Cd) is an 
environmental pollutant with a number of harmful effects and is linked to human 
cancers of l i~ng (Stayner et al. 1992), nasal sinuses Uarup et al. 1998), and prostate 
(Elghany et al. 1990; Arrnstrorig and Kazantzis 1985). It is classified as human 
carcinogen by The International Agency for Research on Cancer (1993) and The 
National Toxicology Program (2000). However, biologically advantageous effects of 
low-level Cd exposure have been reported in different models (Weis and Weis 1986; 
Herkovits and Perez-Coll 1995). Metallothioneins (MTs) are cysteine-rich, low- 
molecular-weight metal-binding proteins that play a major role in the protection of 
cells froin heavy metals such as Cd. In a study with mouse cells (Damelin eta]., 2000) 
horinetic activity fro111 low levels of cadmium chloride was correlated with increased 
levels of Hsp 70 and inetallothionein (MT) indicating a stress response. Achanzar 
et al. (Achanzar et al. 2001) have shown that exposure of normal human prostate 
epithelial cells to cadmium induces malignant transformation. They have also 
demonstrated acquisition of apoptotic resistance in these cadmium-transformed 
cells (Achanrar et al. 2000). The development of resistance to the cancer chemo- 
therapeutic agent adriamycin in cadmiunl-resistant DU-145 human prostate cancer 
cells was demonstrated by Webber et al (Webber et al. 1988). Hormetic effects of Cd 
preexposure were also demonstrated during fin regeneration in fish (Weis and Weis 
1986). 111 the present study we have attempted to determine the protective hormetic 
activity of Cd, using huinan prostate cells. Normal prostate cells were exposed for 
prolonged periods to different low and ultra-low doses of Cd and were analyzed for 
their expression of MT both at protein and mRNA levels. In addition, long-term 
preexposure to low and ultra-low dose Cd was examined for its ability to protect 
prostate cells from malignant transformation from exposure to higher Cd doses. 
MATERIALS AND METHODS 
Cells 
Htunan normal prostate cell line RWPE-1 (Bello et al. 1997; Webber et al. 1997) 
was kindly provided by Dr. Mukta M. Webber, Department of Zoology, Michigan 
State University, East Lansing, MI. These cells were grown in Keratinocyte-serum- 
free medi~uin supplemented with 5 ng/rnl epidermal growth factor (EGF) and 50 
pg/ml bovine pituitary extract (BPE) in the presence of antibiotic-antimycotic 
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solution. Cells were maintained in a humidified incul>ator containing 5%) CO, at 
370C. 
Cd Preparation and Cell Treatment 
Cd solutions were prepared from a 0.01 M CdCI, (Sigma-Aldrich Corp., St. Louis, 
MO) stock solution by 10-fold serial dilutions with Cd-free water. Between each 
dilution they were subjected to 120 manual succussions. RWE-1 cells were exposed 
to Cd at 0, 0 (S39),  lo4, lo-', 10-18, lo9', and 10"" concentrations for 20 
weeks. 0 (SvS6) denotes a treatment with water that was processed in the same way 
as Cd using serial dilutions and succussions but with no Cd added. After 20 weeks, 
these cells were challenged with a higher concentration of Cd (10" M) for 8 weeks. 
This exposure is known to induce malignant transformation of RWPE-1 cells 
(Achanzar et  al. 2001). Cells were subsequently grown in Cd-free n~editun for 
another 4 weeks. Cells were subcultured weekly and subdivided for ~neasurernent of 
cell growth, cell viability, RNA extraction, and MT assays. 
Chemical Analysis of Low and Ultra-Low Dose Cd Preparations and Media 
All solutions and media were analyzed weekly for any extraneous Cd and other 
metal contaminants as follows. Cd concentration in sanlples was determined using 
a graphite furnace atomic absorption spectrometer (GFAAS), (Perkin Elmer Ana- 
lyst 800). Operating conditions included the use of an EDL lamp, wavelength 228.8 
nm and slitwidth 0.7 nm. The background detection limit (BDL) is 0.005 yg/l. The 
BDL was determined as two times the standard deviation (2SD) from an analysis of 
20 consecutive blank solutioi~s with no  Cd added. The method's detection limit is 
between 0.025 and 0.050 pg/l. A four-point calibration curve (standard range from 
0.025 to 3.0 pg/l) was used to determine the Cd concentration in each of the tested 
solutions. Sample blanks, certified standard reference materials (NIST, Gai thersburg, 
MD) , and spiked samples (i.e., samples containing a known amount of an analyte) 
were used for quality assurance. Furthermore, inductively coupled plasma-optical 
emission spectrometry (ICP-OES) (Perkin Elmer Optima 3000) was used to test the 
dilutions for purity and contaminants. A similar quality assurance procedure based 
on the use of sample blanks, standards (0.1 to 30 n~g / l ) ,  certified standard reference 
materials and spiked samples were also used to conduct the ICP-OES measurements. 
The ICP-OES method was used to determine and n~onitor the concentration of 29 
elements (Ag, AI, As, Ba, Be, Ca, Cd, Co, Cr, Cu, Fe, Hg, K, Li, Mg, Mn, Mo, Na, Ni, 
Pb, Sb, Se, Si, Sn, Sr, Ti, TI, V, and Zn). 
Cell Growth and Viability Assays 
RWPE-1 cells were seeded at a concentration of approximately 1 x 10'' cells/T-75 
flask. CdCI, was added in appropriate concentrations, and the cells were passed 
once weekly. During subculture, cells were counted in a suspension after trypsiniza- 
tion for each treatment. Cd treated RWPE-1 cells were plated in 96 well t i s s~~e  
culture plates in a range of 3.0 x 10"cells per well in a final volunle of 100 pl. After 
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24 to 48 11, viability was determined using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- 
diphenyl tetrazolium bromid) assay using Cell Proliferation Kit I (Roche Applied 
Science, Indianapolis, IN) as per the manufacturer's instructions. Briefly, 10 pI of 
MTT labeling reagent was added and incubated for approximately 4 h in a humidi- 
fied incubator at 37"C, 5% CO,. Solubilization solution (100 pl) was then added and 
incul~ated again overnight. The spectrophoton~etrical absorbance was measured 
with a microtiterplate reader at a wavelength of 570 nm (Dynatech Laboratories, 
Chantilly, VA) . 
MT Protein Measurement 
MT protein was quantified, by using the toWd-hemoglobin assay (Eaton and Toal 
1982). Following Cd treatment, cells were harvested with trypsin and lysed in cold 
10 lriM Tris HCl (pH 7.4) by passing through a 24gauge needle. Total protein 
concentration of each sample was determined by using BCA protein assay kit 
(PIERCE, Rockford, IL). Aliquots of the sample were mixed with CdCI, solution 
containing "'!'Cd and hemoglobin. The mixture was heated for 2 min at 100°C and 
centrifuged at 10,000 x g. This step is repeated one more time and radioactivity in 
supernatant was measured. MT levels were normalized to cellular protein. 
mRNA Analysis by RT-PCR 
Cells were harvested and total RNA was prepared using Trizol method (Life 
Technologies, Gaithersburg, MD). PCR primer oligonucleotides for the isoforms of 
MT were as described by Mididoddi et al. (1996) and Barnes et al. (2000). Hsp 70 
primers were purchased from StressGen Biotechnologies Corp, Victoria, BC, Canada. 
Glyceraldehyde-6-phosphate dehydrogenase (GGPDH) primers were obtained from 
Chemicon International Inc. (Temecula, CA) and were used to determine the equal 
levels of target KNAs. Complementary DNA was synthesized using 1 to 2 pg of total 
RNA and Superscript I1 RNase H-reverse transcriptase (Life Technologies, 
Gaitl-~ersburg, MD) following the manufacturer's instructions. PCR reaction mix- 
ture contained 10 pnlol of each primer pair and 2.5 U of Taq DNA polymerase (Life 
Technologies, Gaithersburg, MD). Linear range of amplification of each gene was 
deternlinecl by carrying out 18 to 35 cycles in increments of 3 cycles each. Based on 
the results, amplification reactions were carried out through 20 to 35 cycles (95°C 
to 30 s; 55°C to 45 s; 72°C to 45 s), using 10% of cDNA. PCR products (10 p1 each) 
were analyzed by electrophoresis on 2% agarose gels. Densitometric analysis of the 
PCK products was performed with Instant Imager (Packard, Meriden, CT). 
mRNA Analysis by Ribonuclease Protection Assay (RPA) 
niKNA expression of stress genes in RWPE-1 cells treated with Cd were analyzed 
using Kiboquant multiprobe ribonuclease protection assay kit (BD Biosciences, Palo 
Alto, CA) and North2South Biotin in uitro transcription kit (PIERCE, Rockford, IL). 
The IN-otocols used for the RPA were according to the manufacturer's instructions. 
Briefly, biotinylated RNA probe was prepared by transcribing the hStress-1 template 
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set (bcl-x, p53, GADD45, c-fos, p21, bax, bcl-2, mcl-1, 232, and GAPDH) using T7 
RNA polymerase. 20 pg of total RNA from each sample was hybridized with the 
labeled probe at 56OC for 12 to 14 11. Free probe and unhybridized RNA were 
digested with RNases for 45 min at 30°C. The RNase protected probes were purified 
and resolved on denaturing urea polyacrylamide gels (Invitrogen, Gaithersburg, 
MD). Protected fragments were transferred to Biodyne nylon membrane (PIERCE, 
Rockford, IL) by electrical transfer at around 100 V for 1 ti. Protected probes were 
detected by SuperSignal RPA I11 chemiluminescent Detection Kit (PIERCE, Rock- 
ford, IL) and the membrane was exposed to X-ray film for 1 to 2 niin. L32 and 
GAPDH mRNAs are housekeeping genes and served as controls in the assay to 
ensure equal loading of RNAs. 
Statistical Analysis 
All data are expressed as mean f SEM of 3 to 5 sets of analysis. Data were analyzed 
by using one-way ANOVA and the Tukey-HSD multiple conlparisons test for post 
hoc analysis (SPSS Ver. 10.1, SPSS Inc., Chicago, IL). Significance is defined as a 
p-value of less than 0.05. 
RESULTS 
Chemical analysis for Cd dose in preparations and screening for 29 other poten- 
tial contaminants verified that Cd exposure levels were those predicted by dilution 
level with lo4 M measuring approximately 0.5 mg/l and exposure levels below this 
measuring below the detection limit. No evidence of absorption of change in Cd 
level exposures dilutions was evident over the 20 weeks. Silicon from the glassware 
remained constant in all samples at approximately 0.5 mg/l throughout the experi- 
ment (data not shown). 
In order to study the effect of Cd on RWPE-1, cells were exposed to 0, 0 (S-"'), 
lo4, lo-', 10-la, lo-*', and 10-'% Cd for 20 weeks. Cell proliferation was 
determined by measuring the number of attached cells during each passage. At 
these doses of Cd, no significant changes occurred in the cell morphology (dnta not 
shown) and growth compared to control as shown in Figure 1A from a representa- 
tive data set of one passage. Cytotoxicity as measured by M'IT assay also showed no 
significant differences between Cd treated and untreated control RWPE-1 cells 
(Figure 1B). Taken together, the results of these two assays suggest that at these 
doses Cd did not cause any significant inhibitory or proliferative changes on cell 
growth. 
To determine the modulations in the expression of MT as a consequence of Cd 
treatment, MT protein measurement was performed by ""'Cd-hemoglobrn assay 
(Figure 2). Treatment of RWPE-1 cells with Cd ( lo4', 1 0-', 10-18, 1 O-v, or 10-{() M) 
doses resulted in significant increase in MT protein expression only for lo-" M 
concentration. A representative data set for MT protein levels from the third week 
of treatment is shown in Figure 2A. Furthermore, this increased MT level was 
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rnaintained during the prolonged Cd exposure through 20 weeks (Figure 2B). 
Challenging these 20 weeks low-dose Cd pretreated cells with 10" MCd for another 
8 weeks increased in MT levels further for all treatments (Figure 2C). Although the 
increase was higher in all Cd pretreated cells, it was statistically significant only for 
the lo-" and MCd pretreated cells when compared to passage matched positive 
controls. Growing these pretreated cells (lo-" to lo-" M Cd for 20 weeks followed 
by treatment with 1 0 - M  Cd for 8 weeks) in normal media (0 M Cd) for another 4 
weeks resulted in transformation. However, the cells pretreated with low and ultralow 
doses of Cd were slow in developing the transformed cell mounds compared to 
controls (Figure 3). Also, the number of transformed cell mounds was 35% less in 
pretreated cells compared to controls, indicating a protective effect from lowdose 
pretreatments. Analysis of these cells showed significant difference in MT levels 
between lo4 M Cd treatnlent and controls (Figure 2D). Treatment with succussed 
water [Cd 0 (S-"9) did not show any significant differences, and the cell behavior 
and expression pattern were similar to normal cells (Figures 2A, B, and C). 
We have investigated the mRNA expression by semiquantitative RT-PCRfor all 10 
functional MT isoforms in RWPE-I cells subjected to Cd treatment as detailed 
above. No significant differences were observed for any of the isoforms between 
controls and Cd exposed cells except for MT-1G. Increased expression (2- to 3-fold) 
of isoform MT-1G with Cd exposure is nlaintained for all low and ultra-low levels 
(Figure 4) and throughout the treatment duration of 20 weeks. No significant 
differences in rnRNA levels were observed between controls of low dose Cd exposed 
cells for stress genes bcl-x, p53, GADD45, c-fos, p21, bax, bcl-2, mcl-1 as analyzed by 
KPA (data not presented). No significa~lt changes occurred in the mRNA expres- 
sion of Hsp 70 as analyzed by KT-PCR for any of the treatments (Figure 4). 
DISCUSSION 
Hor~netic effects of harmful substances, have been reported since the 19& cen- 
tury by Schulz (1887, 1888), yet their mechanisms remain largely uninvestigated. 
Bukowski and Lewis (2000) have reviewed hormetic patterns in a wide range of 
examples including humans and concluded that it nlay be a universal phenomenon. 
The idea that low-dose stimulatory effects may be useful for subsequent cellular 
protection is a new concept; however, its scope and mechanisms are largely un- 
known. We have explored this phenonlenon by analyzing changes in mRNA and 
protein levels in normal prostate cells exposed to low and ultralow dose Cd. The 
results obtained in this study indicate that prolonged exposure to low dose Cd 
induces tolerance toward higher doses of Cd and induces metallothionein expres- 
s i o ~ ~ .  Higher levels of MT were maintained even after 4 weeks of growth in Cd-free 
media when followed by treatment with a higher concentration of Cd. In addition, 
MT mRNA is upregulated by both low and ultralow Cd exposure, although almost 
exclt~sively in the MT-1G isoform. These observations are consistent with the find- 
ings of Croute et al. (2000), where human lung cells (A549) exposed to 0.1, 1, or 
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Figure 3. Growth of RWPE-1 cells after Cd treatments. (A) Monolayer of cells in tin- 
treated control. (B) Cells after treatment with 1 0 - M C d  for 8 weeks followed by 
growth in normal media show clumping, whereas (C) similar treatment to long- 
term Cd pretreated cells resulted in clumps of smaller size and fewer in number. 
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Figure 4. Effect of low-dose Cd on mRNA expression of MT-lG, Hsp 70, and GAPDH in 
RWPE-1 cells as analyzed by RT-PCR. Representative picture showing PCR 
products froin cells treated with low and ultralow doses of Cd for 20 weeks. 
(A) Increased levels of MT-IG mRNA (2- to 3-fold) and densitometric analysis 
from three experiments show no significant difference between Cd-treated 
specimens (data not shown). (B) No significant changes were observed in Hsp 
70 levels. (C) Equal amounts of RNA were checked by analyzing GAPDH expres- 
sion. 
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10 pM Cd for 4 or 31 days overexpressed MT. In addition, prolonged exposure of 
mice to low dose Cd through diet resulted in inhibition of spontaneous carcinogen- 
esis, which was attributed to increased MT production (Nishiyama et al. 2003). 
Others have also found that exposure of mice to low dose Cd for 11 to 12 weeks does 
not cause pronounced cytogenetic effects (Osipov 2002). Pretreatnlent with low 
dose Cd has been shown by several groups to induce tolerance against lethal dose 
of Cd in rats (Klaassen and Liu 1997; Delbancut et al. 1997). Similarly, Rz&/o izrt.nnrum 
embryos developed significant resistance against Cd toxicity with low-dose Cd pre- 
treatment (Herkovits and Perez-Coll 1995). BGCSF1 mice treated with 
nitrosodiethylamine followed by Cd treatment suppressed spontaneous liver tumors 
and reduced the incidence of lung tumors (Waalkes et  al. 1991, 1996), and again 
a role for metallothionein was demonstrated. There are also reports demonstrating 
beneficial effects of low-dose treatments other than Cd (Linde et al. 1994). 
It is well known that MT plays a major role in the cellular kinetics and metaholisni 
of Cd. Multiple functions of MTs, including their role in protection against Cd 
toxicity, are reviewed by Klaassen et al. (1999). Mammalian MTs belong to Class I 
and are composed of four subfamilies MT-1, MT-2, MT-3, and MT-4. A total of 10 
functional and 6 nonfunctional MT isoforms have been identified in humans 
(Quaife et al. 1994; Palmiter et al. 1992; West et al. 1990; and Stennard et al. 1994). 
The role of these subfamilies and isofornis in metal ho~neostasis and detoxification 
are not completely clear. Only 1 of the 10 isoforms, MT-lG, showed a change in 
mRNA expression in the long-term, low-, and ultralow-dose exposed cells. NO 
expression of MT-lG was detected either in normal human prostate tissues or in 
human prostate cancer cell lines DU-145, PC-3, and LNCaP (Garett et al. 2000). The 
induction of MT-1G with all low doses and its continued expression during the 20- 
week Cd treatment suggests a functional significance for this isoform in cell trans- 
formation even in the absence of increased MT production. Other isoforms did not 
have similar mRNA up-regulation patterns, suggesting that they riiay not he rnedia- 
tors of lowdose Cd-induced protection. However, they may be contributing for 
overall protein content. 
Continuous treatment with 10 pM Cd induces transformation of KWPE-1 cells 
and acquires apoptotic resistance, forming cell mounds (Achanzar et al. 2001, 
2002). The change in cellular sensitivity after exposure to low-dose Cd and the 
modulation of MT expression is one possible explanation for the reduced transfor- 
mation observed in our experiments. Hormetic effect of a 0.5 n~g/liter Cd 
preexposure during fin regeneration in fish was significant over 0.1 mg/l treatment 
(Weis and Weis 1986). The lack of hormetic response at lower dose treatment may 
be due to inadequate preexposure time. Besides MTs, there may be other cellular 
processes that contribute for protection, and these need to be evaluated. We found 
both reduced and delayed transformation in cells preexposed to low- and ultralow 
dose Cd when MT-IG mRNA levels were up-regulated regardless of whether MT 
proteins were also effected. This suggests a central role for MT-1G mRNA in cellular 
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protection from high dose Cd. In addition, MT-1G may be a sensitive biomarker for 
the detection of low and ultralow-dose enviro~lmental exposure to Cd. 
In concl~~sion,  our  experiments show that long-term exposure of normal prostate 
cells to Cd at low and ultralow-doses impart biolo@cal activity resulting in protection 
against toxic doses. These observations also provide insights into possible mecha- 
11isms of action and are relevant to furthering our  understanding of horlnetic 
phenomenon. Further studies are in progress using inicroarray technology in order 
to examine possible low-dose Cd-induced gene expressiori signatures. 
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